In The Know: Where do T2DM brand loyalties lie in Europe?

How do European physicians rate therapies for type 2 diabetes mellitus (T2DM)? When 150 diabetologists and primary care physicians from Spain, Italy, France, Germany and the UK were asked to rate treatment options, they gave Januvia the highest ranking, five points higher than second place NovoRapid, in terms of overall brand satisfaction (see Table 1).

Table 1: T2DM therapies ranked by European physicians for brand satisfaction

Source: FirstWord NPS+ (EU5) -- Type 2 Diabetes Mellitus (2017)

Based on the Net Promoter Score (NPS) system, six out of 12 brands featured in the 2017 survey received positive scores. The scores indicate that brand health differs greatly across the available therapies. Due to the growing number of diabetes treatment options on the market, the 2018 surveys will be broken down into two categories, injectable and oral medications. Responses to the latest T2DM injectables survey will be available in the coming weeks and will show how this market is ranked by European physicians (click here to be notified when results are available).

Table 2: Brands included in the upcoming T2DM injectables 2018 survey

FirstWord has conducted similar research in 15 competitive disease areas across the US and EU. Contact us to learn more.

To read more Sponsored Story articles, click here.

Reference Articles